CDNA
CareDx, Inc.
Diagnostics & Research · Healthcare · United States
47.38
close · 2026-08-13
value
22
cheaper than peers22
quality
96
stronger fundamentals96
ranked against
Diagnostics & Research
value
quality
28 peers
Value inputs
| measure | company | vs peers |
| price to sales | 5.14× | 50 |
| price to book | 5.73× | 48 |
| forward P/E | 34.97× | 24 |
| EV to EBITDA | 170.60× | 3 |
4 of 12 measures available
Quality inputs
| measure | company | vs peers |
| revenue growth | 52.2% | 95 |
| debt to equity | 4.5% | 90 |
| return on equity | 29.5% | 87 |
| operating margin | 0.2% | 46 |
4 of 4 measures available
Facts
| market cap | $2B |
| free cash flow | $112.2M |
| employees | 761 |
| first trade | 2014-07-17 |
| next earnings | 2026-07-30 |
| fundamentals updated | 2026-08-05 |